About 5 results found for searched term "Ceranib 1" (0.134 seconds)
| Cat.No. | Name | Target |
|---|---|---|
| M1956 | Apatinib mesylate | VEGFR/PDGFR |
| Rivoceranib mesylate; YN968D1 | ||
| Apatinib is a small-molecule multitargeted tyrosine kinase inhibitor of VEGFR2 with an IC50 of 2.43 nM. | ||
| M6578 | Ceranib 1 | Others |
| Ceranib 1 is a ceramidase inhibitor; antiproliferative. | ||
| M5342 | Toceranib | VEGFR/PDGFR |
| su-11654; pha-291639 | ||
| Toceranib(SU 11654; PHA 291639) is a kinase inhibitor with both antitumor and antiangiogenic activity through inhibition of KIT, vascular endothelial growth factor receptor 2, and PDGFRβ. | ||
| M20877 | Toceranib phosphate | VEGFR/PDGFR |
| SU11654 | ||
| Toceranib phosphate is a multitargeted indolinone receptor tyrosine kinase (RTK) inhibitor with Kis of 5 and 6 nM for PDGFRβ and Flk-1/KDR, respectively. | ||
| M55044 | Ceranib-2 | LPL Receptor |
| Ceranib-2 is a potent and nonlipid ceramidase inhibitor that inhibits cellular ceramidase activity with an IC50 of 28 μM in SKOV3 cells. Ceranib-2 decreases levels of sphingosine and S1P, induces cell apoptosis and exhibits anticancer activity. | ||
Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2024 AbMole BioScience. All Rights Reserved.
